Henrik Alm

611 total citations
11 papers, 479 citations indexed

About

Henrik Alm is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Henrik Alm has authored 11 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Henrik Alm's work include Pluripotent Stem Cells Research (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Henrik Alm is often cited by papers focused on Pluripotent Stem Cells Research (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Henrik Alm collaborates with scholars based in Sweden, United Kingdom and France. Henrik Alm's co-authors include Per Eriksson, Torsten Gordh, Anders Fredriksson, Trevor Archer, Birger Scholz, Kim Kultima, Lennart Dencker, Michael Stigson, Per E. Andrén and Karl Sköld and has published in prestigious journals such as PLoS ONE, Environmental Health Perspectives and BMC Bioinformatics.

In The Last Decade

Henrik Alm

10 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik Alm Sweden 9 169 133 105 100 99 11 479
Anthony C Kuhlmann United States 8 81 0.5× 235 1.8× 303 2.9× 11 0.1× 12 0.1× 8 655
Sonja Buratovic Sweden 11 104 0.6× 119 0.9× 50 0.5× 4 0.0× 11 0.1× 19 485
Ramin Siushansian Canada 8 108 0.6× 10 0.1× 155 1.5× 23 0.2× 17 0.2× 8 573
Kazuya Shiraishi United States 6 61 0.4× 12 0.1× 301 2.9× 60 0.6× 4 0.0× 8 671
Dawn S. Carter United States 11 29 0.2× 68 0.5× 349 3.3× 9 0.1× 3 0.0× 11 617
Yueming Huang United States 11 137 0.8× 2 0.0× 208 2.0× 53 0.5× 20 0.2× 15 400
Laure Barbier France 11 39 0.2× 25 0.2× 153 1.5× 2 0.0× 16 0.2× 20 446
Veit‐Simon Eckle Germany 11 66 0.4× 7 0.1× 235 2.2× 12 0.1× 29 0.3× 24 453
R. Widmann Germany 7 42 0.2× 39 0.3× 101 1.0× 85 0.8× 7 429
L. J. Bryan‐Lluka Australia 15 15 0.1× 6 0.0× 287 2.7× 12 0.1× 26 0.3× 38 614

Countries citing papers authored by Henrik Alm

Since Specialization
Citations

This map shows the geographic impact of Henrik Alm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Alm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Alm more than expected).

Fields of papers citing papers by Henrik Alm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Alm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Alm. The network helps show where Henrik Alm may publish in the future.

Co-authorship network of co-authors of Henrik Alm

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Alm. A scholar is included among the top collaborators of Henrik Alm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Alm. Henrik Alm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Fritsche, Ellen, Henrik Alm, Jenny Baumann, et al.. (2015). Literature review on in vitro and alternative Developmental Neurotoxicity (DNT) testing methods. EFSA Supporting Publications. 12(4). 45 indexed citations
3.
Sköld, Karl, Henrik Alm, & Birger Scholz. (2013). The Impact of Biosampling Procedures on Molecular Data Interpretation. Molecular & Cellular Proteomics. 12(6). 1489–1501. 19 indexed citations
4.
Scholz, Birger, Henrik Alm, Anna Mattsson, et al.. (2010). Neuropeptidomic analysis of the embryonic Japanese quail diencephalon. BMC Developmental Biology. 10(1). 30–30. 10 indexed citations
5.
Alm, Henrik, Birger Scholz, Kim Kultima, et al.. (2009). In Vitro Neurotoxicity of PBDE-99: Immediate and Concentration-Dependent Effects on Protein Expression in Cerebral Cortex Cells. Journal of Proteome Research. 9(3). 1226–1235. 26 indexed citations
6.
Scholz, Birger, Marcus Svensson, Henrik Alm, et al.. (2008). Striatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure. PLoS ONE. 3(2). e1589–e1589. 37 indexed citations
7.
Alm, Henrik, Kim Kultima, Birger Scholz, et al.. (2008). Exposure to brominated flame retardant PBDE-99 affects cytoskeletal protein expression in the neonatal mouse cerebral cortex. NeuroToxicology. 29(4). 628–637. 64 indexed citations
8.
Stigson, Michael, Kim Kultima, Birger Scholz, et al.. (2007). Molecular Targets and Early Response Biomarkers for the Prediction of Developmental Toxicity In Vitro. Alternatives to Laboratory Animals. 35(3). 335–342. 5 indexed citations
10.
Alm, Henrik, Birger Scholz, Celia Fischer, et al.. (2005). Proteomic Evaluation of Neonatal Exposure to 2,2′,4,4′,5-Pentabromodiphenyl Ether. Environmental Health Perspectives. 114(2). 254–259. 61 indexed citations
11.
Fredriksson, Anders, Trevor Archer, Henrik Alm, Torsten Gordh, & Per Eriksson. (2004). Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behavioural Brain Research. 153(2). 367–376. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026